Proto Labs Inc: Form 10-Q for the period ended Mar 31, 2016
Filed with the SEC on May 5, 2016 and accepted by EDGAR at May 5, 2016, 15:02 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2016-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2016-01-01 to 2016-03-31 | $72.6m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2016-01-01 to 2016-03-31 | $32.9m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2016-01-01 to 2016-03-31 | $39.7m | us-gaap:GrossProfit |
| Research and development | 3 months2016-01-01 to 2016-03-31 | $5.3m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2016-01-01 to 2016-03-31 | $15.1m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2016-01-01 to 2016-03-31 | $5.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2016-01-01 to 2016-03-31 | $10.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2016-01-01 to 2016-03-31 | $0.40 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2016-01-01 to 2016-03-31 | $0.41 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2016-01-01 to 2016-03-31 | 26,442,357 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2016-01-01 to 2016-03-31 | $16.9m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 3 months2016-01-01 to 2016-03-31 | $8.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2016-03-31 | $50.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2016-03-31 | $144.1m | us-gaap:AssetsCurrent |
| Total assets | At period end2016-03-31 | $374.8m | us-gaap:Assets |
| Current liabilities | At period end2016-03-31 | $23.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2016-03-31 | $31.1m | us-gaap:Liabilities |
| Shareholders' equity | At period end2016-03-31 | $343.7m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-16-030937. Last ingested by Listed: Nov 4, 2026, 18:20 ET. Listed shows no prices and gives no investment advice.